References
- Rothova A, Suttorp-von Shulten MS, Fritz Trefers WF, et al. Causes and frequency of blindness in patients with intra-ocular inflammatory disease. Br J Ophthalmol 1996;80:332–336.
- Lazar M, Weiner M, Leopold I. Treatment of uveitis with methotrexate. Am J Ophthalmol 1969;3:383–387.
- Weinstein GD, Frost P. Methotrexate for psoriasis: a new therapeutic schedule. Arch Dermatol 1971;1o3:33–38.
- Roenig HH, Maibach HI, Weinstein G. Guidelines on methotrexate therapy for psoriasis. Arch Dermatol 1972;105:362–363.
- Wilke WS, Biro JA, Segal AM. Methotrexate in the treatment of arthritis and connective tissue diseases. Cleveland Clin J Med 1987;54:327–338.
- Weinblatt ME, Trentham DE, Fraser PA, et al. Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis. Arthritis Rheum 1988;31:167–175.
- Gilman AG, Goodman LS, Rall TW, Murad E The Pharmacological Basis of Therapeutics. New York: Macmillan Publishing Company, 1985;1264 p.
- Wong VG. Methotrexate treatment of uveal disease. Am J Sci 1966; 251:239–241.
- Shah SS, Lowder CY, Schmitt MA, et al. Low dose methotrexate therapy for ocular inflammatory disease. Ophthalmology 1992;99: 1419–1423.
- Holz FG, Krastel H, Breitbart A, et al. Low dose methotrexate treatment in noninfectious uveitis resistant to corticosteroids. Ger J Ophthalmol 1992;1:142–144.
- Dev S, McCallum R, Jaffe G. Methotrexate treatment, for sarcoid associated panuveitis. Ophthalmology 1999;106:H1—H8.
- Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 1987;103:234–235.
- Kremer JM, Lee JK. The safety and efficacy of the use of methotrexate efficacy of the use of methotrexate in long term therapy for rheumatoid arthritis. Arthritis Rheumatol 1986;29:822–831.
- Axehod L. Glucocorticoid therapy. Medicine (Baltimore) 1976;55:39–65.
- Hemady R, Tauber J, Foster S. Immunosuppressive drugs in immune and inflammatory ocular disease. Surv Ophthalmol 1991; 35(5):369–385.
- Olsen NJ, Murray LM. Antiproliferative effects of Antiproliferative effects of methotrexate on peripheral blood mononuclear cells. Arthritis Rheum 1989;32:378–385.
- Kerwar SS, Oronsky AL. Methotrexate in rheumatoid arthritis: studies with animal models. Adv Enzyme Regul 1989;29:247–265.
- Cronstein BN. Molecular mechanism of methotrexate action in inflammation. Inflammation 1992;16:411–423.
- Andersen EA,West SG, O’Dell JR, et al.Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomised, double-blind study. Ann Intern Med 1985;103:489–496.
- Weinblatt ME, Coblyn JS, Fox DA, et al. Efficacy of low dose methotrexate in rheumatoid arthritis. N Engl J Med 1985;312:818–822.
- Segal AM, Wilke WS. Toxicity of low dose methotrexate in rheumatoid arthritis. In: Wilke WS, editor. Methotrexate Therapy in Rheumatic Disease. New York: Marcel Dekker, 1989;147–178.
- Tolman KG, Clegg DO, Lee RG, et al. Methotrexate and the liver. J Rheum 1985;12 12:29–34.
- Kremer JM, Alancon GS, Lightfoot RW, et al. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. Arthritis Rheum 1997;40:2226–2234.
- Preston SJ, Diamond T, Scott A, et al. Methotrexate osteopathy in rheumatic disease. Ann Rheum Dis 1993;52:582–585.
- Bleyer WA. Methotrexate induced lymphoma? J Rheum 1998;25:404–407.
- Vitale AT, Rodriguez A, Foster S. Low dose cyclosporine A therapy in treating chronic, non-infectious uveitis. Ophthalmology 1996;103:365–374.
- Towler HM, Cliffe AM, Whiting PH, Forrester JV. Low dose cyclosporine A therapy in chronic posterior uveitis. Eye 1989;3\(pt 3):282–287.
- Mochizuki M, Maserda K, Sakane T, et al. A clinical trial of FK-506 in refractory uveitis. Am J Ophthalmol 1993;115:763–769.
- Andrasch RH, Pirofsky B, Burns RP. Immunosuppressive therapy for severe chronic uveitis. Arch Ophthalmol 1978;96:247–251.
- Ishioka M, Ohno S, Nakamura S, et al. FK 506. Treatment of non-infectious uveitis. Am J Ophthalmol 1994;118:723–729.
- Larkin G, Lightman S. Mycophenolate mofetil: a useful immunosuppressive in inflammatory eye disease. Ophthalmology 1999;106:370–374.
- Kilmartin D, Forrester J, Dick A. Rescue therapy with mycophenolate mofetil in refractory uveitis. Lancet 1998;352:35–36.